Antisense oligonucleotide-based therapeutic against menin for triple-negative breast cancer treatment

HIGHLIGHTS

  • who: Dang Tan Nguyen et al. from the Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de (CRCM), CNRS, Institut Paoli-Calmettes, BdLeï, in Medical Imaging, France have published the article: Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment, in the Journal: Biomedicines 2021, 9, x FOR PEER REVIEW of 30/Dec/2020
  • what: The authors have aimed to investigate the expression of menin in various TNBC cells and assess the effects of specific ASO-driven menin inhibition on apoptosis and tumor progression in_vitro and in_vivo using the TNBC Hs . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?